SCHEMBL6772376

SCHEMBL6772376

O=C(O)c1ccc(C(=O)O)c(Cc2ccccc2)c1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.69
KDM4E B2RXH2 1/20 0.58
PTPN1 P18031 4/20 0.56
PTPN2 P17706 1/20 0.56
PTPN6 P29350 1/20 0.56
CDC25A P30304 1/20 0.50
CDC25B P30305 1/20 0.50
HSD17B10 Q99714 1/20 0.50
HNF4A P41235 1/20 0.50
MBTD1 Q05BQ5 1/20 0.48
L3MBTL3 Q96JM7 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
PLA2G2A P14555 2/20 0.48
PLA2G10 O15496 1/20 0.47
LMNA P02545 1/20 0.47
BCL2 P10415 1/20 0.47
BCL2L1 Q07817 1/20 0.47
SRD5A2 P31213 1/20 0.46
FOLH1 Q04609 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1646865 0.91 TSHR (0.71) TSHRKDM4EPTPN1PTPN2PTPN6
SCHEMBL2428547 0.90 PLA2G2A (0.57) TSHRKDM4EPTPN1PTPN2PTPN6
SCHEMBL16584765 0.90 PLA2G2A (0.59) TSHRKDM4EPTPN1PTPN2PTPN6
SCHEMBL4521739 0.87 TSHR (0.72) TSHRKDM4EPTPN1PTPN2PTPN6
SCHEMBL31307947 0.87 TSHR (0.61) TSHRKDM4EPTPN1PTPN2PTPN6
SCHEMBL8579535 0.86 KDM4E (0.57) TSHRKDM4EPTPN1PTPN2PTPN6
SCHEMBL7941034 0.86 TSHR (0.60) TSHRKDM4EPTPN1PTPN2PTPN6
SCHEMBL30438068 0.85 KMT2A (0.58) TSHRKDM4EPTPN1PTPN2PTPN6
SCHEMBL8961442 0.85 PTPN1 (0.65) TSHRPTPN1PTPN2PTPN6CDC25B
SCHEMBL6653761 0.84 SRD5A2 (0.60) TSHRKDM4EHSD17B10HNF4ASRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577645-A1 ENZYME VARIANTS AND USES THEREOF Samsara Eco Pty Limited (AU) 2025-07-02 EP disclosed
WO-2024040304-A1 ENZYME VARIANTS AND USES THEREOF SAMSARA ECO PTY LIMITED (AU) 2024-02-29 WO disclosed
CN-105764883-B Thermoplastic polymer composition 美利肯公司 2019-06-04 CN disclosed
CN-1592729-A Process for preparing pentacene derivatives 3M INNOVATIVE PROPERTIES CO (US) 2005-03-09 CN disclosed
US-6693123-B2 (4-(3-PYRIDYLAMINOMETHYLENE)-2-PHENYLBENZOYL)-N -METHYLMETHIONINE, METHYL ESTER FOR EXAMPLE; RESTENOSIS, HYPERPLASIA UNIVERSITY OF PITTSBURGH 2004-02-17 US disclosed
EP-0873123-B1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIV PITTSBURGH (US) 2003-04-09 EP disclosed
US-20020193596-A1 Inhibitors of protein isoprenyl transferases UNIVERSITY OF PITTSBURGH (US) 2002-12-19 US disclosed
EP-0873123-A4 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIV PITTSBURGH (US) 1999-02-03 EP disclosed
EP-0873123-A1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1998-10-28 EP disclosed
WO-1997017070-A1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1997-05-15 WO disclosed
EP-0380677-A1 FLUORAN COMPOUNDS AND COLOR-FORMING RECORDING MATERIALS CONTAINING SAME NIPPON SODA CO., LTD. (JP) 1990-08-08 EP disclosed
EP-0133225-B1 PEPTIDE DERIVATIVES AND THEIR SALTS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM, PROCESS AND INTERMEDIATES FOR THEIR PRODUCTION F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1988-10-19 EP disclosed
EP-0133225-A2 Peptide derivatives and their salts, pharmaceutical preparations containing them, process and intermediates for their production F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1985-02-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193596-A1 Inhibitors of protein isoprenyl transferases LANCL1, FNTB, DHCR7 TSHR 2542/4885KDM4E 3061/4885PTPN1 2866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.